Literature DB >> 393519

Hypotensive action and side-effects of flutonidin in normal subjects. A double-blind controlled trial.

P Sala, S M Chierichetti, P Ferrari.   

Abstract

In a double blind study, planned as a 7 x 7 latin square, three oral doses of flutonidin (0.5, 1, 2 mg), of clonidine (0.0075, 0.150, 0.300 mg) and of a placebo were administered to 7 normal volunteers on 7 different treatment days, with an interval of 3 days. On each treatment day sitting blood pressure, heart rate and reaction time were measured, and sedation and dry mouth evaluated before the 1, 2, 3, 4, 6, and 8 h after administration. The placebo did not modify the basal value of any variable. Flutonidin and clonidine produced dose-related effects on blood pressure, heart rate, sedation and dry mouth, but did not influence reaction time. Analysis of the dose-response curves demonstrated that the effect of flutonidin was one-fifth to one-twelfth that of clonidine, depending on which variable was considered.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 393519     DOI: 10.1007/bf00568196

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  [A new antihypertensive imidazoline derivative (St 600, Fluoronidine): I. Haemodynamic investigations at rest and during exercise (author's transl)].

Authors:  S Djawan; J Mlezoch; M Niederberger; E Penner; G Grabner
Journal:  Wien Klin Wochenschr       Date:  1976-03-19       Impact factor: 1.704

2.  A comparison of the behavioural effects of some hypotensive imidazoline derivatives in rats.

Authors:  R Laverty
Journal:  Eur J Pharmacol       Date:  1970-02       Impact factor: 4.432

3.  A further attempt to characterize sedative receptors activated by clonidine in chickens and mice.

Authors:  B Delbarre; H Schmitt
Journal:  Eur J Pharmacol       Date:  1973-06       Impact factor: 4.432

4.  Pharmacokinetics and side-effects of clonidine.

Authors:  A Keränen; S Nykänen; J Taskinen
Journal:  Eur J Clin Pharmacol       Date:  1978-05-17       Impact factor: 2.953

5.  [First observations on an antihypertensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride in man].

Authors:  D Michel; W Zimmermann; A Nassehi; P Seraphim
Journal:  Dtsch Med Wochenschr       Date:  1966-09-02       Impact factor: 0.628

6.  [Clinical and clinical-experimental studies with a new blood pressure lowering substance: dichlorophenylaminoimidazoline].

Authors:  K D Bock; V Heimsoth; P Merguet; J Schönermark
Journal:  Dtsch Med Wochenschr       Date:  1966-10-07       Impact factor: 0.628

7.  Within-patient comparisons between different anti-hypertensive drugs.

Authors:  B Harvald
Journal:  Clin Sci Mol Med Suppl       Date:  1976-12

8.  Relationship between activity and structure in derivatives of clonidine.

Authors:  W Hoefke; W Kobinger; A Walland
Journal:  Arzneimittelforschung       Date:  1975-05

9.  [New antihypertensive agent of the imidazoline series: 5-fluoro-methyl-imidazolidinylidene-benzamine-monohydrochloride (flutonidin)].

Authors:  H Brunner; S Djawan; W Dorda; E Penner; G Grabner
Journal:  Arzneimittelforschung       Date:  1977

10.  Haemodynamic and endocrine changes during anti-hypertensive treatment with clonidine and its derivative St 600.

Authors:  T L Kho; G A Zaal; A Wester; P W de Leeuw; W H Birkenhäger
Journal:  Clin Sci Mol Med Suppl       Date:  1976-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.